Cargando…

The virtually mature B‐type natriuretic peptide (BNP1‐32) is a precursor for the more effective BNP1‐30

BACKGROUND AND PURPOSE: The B‐type natriuretic peptide (BNP1‐32) exerts vasorelaxing and cardioprotective activity. BNP is used as a biomarker for the diagnosis of cardiopathological conditions and recombinant BNP1‐32 as a drug for the treatment of such. BNP1‐32 has a short half‐life and thus, simil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwiebs, Anja, Wang, Yong, Moore, Andrew M., Zhu, Xudong, Pankow, Kristin, Siems, Wolf‐Eberhard, Walther, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056463/ https://www.ncbi.nlm.nih.gov/pubmed/31691951 http://dx.doi.org/10.1111/bph.14890

Ejemplares similares

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)

Impact of high intensity interval and moderate continuous training on plasma ratios of ProBNP(1-108)/BNP(1-32) and NT-pro-BNP(1-76)/BNP(1-32) after coronary artery bypass grafting surgery
por: Zare Karizak, Sara, et al.
Publicado: (2023)

Pregnancy-specific Reference Intervals for BNP and NT-pro BNP—Changes in Natriuretic Peptides Related to Pregnancy
por: Dockree, Samuel, et al.
Publicado: (2021)

Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP)
por: Maries, Lorena, et al.
Publicado: (2013)

Brain Natriuretic Peptide (BNP) and N-Terminal-proBNP in Cardio-Renal Anemia Syndrome　― Difference in Prognostic Ability ―
por: Otaki, Yoichiro, et al.
Publicado: (2019)

Direct Immunochemiluminescent Assay for proBNP and Total BNP in Human Plasma proBNP and Total BNP Levels in Normal and Heart Failure
por: Nishikimi, Toshio, et al.
Publicado: (2013)

B-Type Natriuretic Peptide (BNP) Revisited—Is BNP Still a Biomarker for Heart Failure in the Angiotensin Receptor/Neprilysin Inhibitor Era?
por: Nishikimi, Toshio, et al.
Publicado: (2022)

Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP – A narrative review
por: Kerr, Brian, et al.
Publicado: (2022)

Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023)

Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013)

Depletion of proBNP(1-108) in Patients with Heart Failure Prevents Cross-Reactivity with Natriuretic Peptides
por: Roubille, François, et al.
Publicado: (2013)

A Novel Bioassay for the Activity Determination of Therapeutic Human Brain Natriuretic Peptide (BNP)
por: Yu, Lei, et al.
Publicado: (2012)

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
por: Lewis, Robert A., et al.
Publicado: (2020)

Brain natriuretic peptide precursor (NT-pro-BNP) levels predict for clinical benefit to sunitinib treatment in patients with metastatic renal cell carcinoma
por: Papazisis, Konstantinos T, et al.
Publicado: (2010)

B-type natriuretic peptide (NT-proBNP) and thyroid function: study in elderly subjects
por: Mastroianni, S, et al.
Publicado: (2010)

BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine
por: Cao, Zhipeng, et al.
Publicado: (2019)

Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
por: Alawieh, Hussein, et al.
Publicado: (2019)

B-Type Natriuretic Peptides (BNP) and Tissue Doppler E/e´ Before and After 4 Weeks Standard Treatment of African Heart Failure Subjects: The ABU-BNP Longitudinal Survey
por: Onyemelukwe, Obiageli Uzoamaka, et al.
Publicado: (2019)

B-Type Natriuretic Peptides (BNP) and Tissue Doppler E/e´ Before and After 4 Weeks Standard Treatment of African Heart Failure Subjects: The ABU-BNP Longitudinal Survey [Corrigendum]
Publicado: (2020)

Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population Cohort
por: Welsh, Paul, et al.
Publicado: (2022)

Serial, Repeated, or Single Measurements of Natriuretic Peptides (BNP or NT‐proBNP) in Estimating Cardiovascular Risk: Is It the “Importance of Change Over Time” or “The Past Is Good, But the Present Is Better,” or Both, in Clinical Context?
por: Miller, Wayne L.
Publicado: (2022)

A comparison of the prognostic value of BNP versus NT-proBNP after hospitalisation for heart failure
por: Linssen, G. C. M., et al.
Publicado: (2018)

BNP and Precision Medicine: Tip of an Iceberg
por: Lanfear, David E., et al.
Publicado: (2021)

Impact of DPP-4 inhibitors on plasma levels of BNP and NT-pro-BNP in type 2 diabetes mellitus
por: Mu, Liying, et al.
Publicado: (2022)

Doppler Echocardiography Combined with NTproBNP/BNP in the Diagnosis of Pulmonary Artery Hypertension Associated with Congenital Heart Disease
por: Zhang, Xi, et al.
Publicado: (2023)

Diagnostic value of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP) and their correlation with lipoproteins in dogs with myxomatous mitral valve disease
por: Khaki, Zohreh, et al.
Publicado: (2022)

High Serum Levels of Pro-Brain Natriuretic Peptide (pro BNP) Identify Cardioembolic Origin in Undetermined Stroke
por: Rodríguez-Yáñez, Manuel, et al.
Publicado: (2009)

A rapid reporter assay for recombinant human brain natriuretic peptide (rhBNP) by GloSensor technology
por: Yu, Lei, et al.
Publicado: (2018)

The effects of super-flux (high performance) dialyzer on the plasma glycosylated pro-B-type natriuretic peptide (proBNP) and glycosylated N-terminal proBNP in end-stage renal disease patients on dialysis
por: Nakagawa, Yasuaki, et al.
Publicado: (2013)

The Effects of Super-Flux (High Performance) Dialyzer on Plasma Glycosylated Pro-B-Type Natriuretic Peptide (proBNP) and Glycosylated N-Terminal proBNP in End-Stage Renal Disease Patients on Dialysis
por: Nakagawa, Yasuaki, et al.
Publicado: (2014)

Change in the NT‐proBNP/Mature BNP Molar Ratio Precedes Worsening Renal Function in Patients With Acute Heart Failure: A Novel Predictor Candidate for Cardiorenal Syndrome
por: Takahama, Hiroyuki, et al.
Publicado: (2019)

MiR30‐GALNT1/2 Axis‐Mediated Glycosylation Contributes to the Increased Secretion of Inactive Human Prohormone for Brain Natriuretic Peptide (proBNP) From Failing Hearts
por: Nakagawa, Yasuaki, et al.
Publicado: (2017)

Cardiac Complications in Pregnancy: A Systematic Review and Meta-Analysis of Diagnostic Accuracy of BNP and N-Terminal Pro-BNP
por: Sheikh, Mahboobeh, et al.
Publicado: (2021)

NT‐proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme
por: Sweeney, Claire, et al.
Publicado: (2021)

Subclinical elevated B-type Natriuretic Peptide (BNP) indicates endothelial dysfunction contributing to hypoxia susceptibility in healthy individuals
por: Khatri, Rahul, et al.
Publicado: (2020)

Optimal cut points of N-terminal of the prohormone brain natriuretic peptide (NT-proBNP) in patients with COVID-19
por: Chehrazi, Mohammad, et al.
Publicado: (2022)

Proposal to restructure the BNP Paribas Fortis loan
Publicado: (2020)

Redesign des Controllings bei BNP Paribas
por: Nobach, Kai, et al.
Publicado: (2020)

BNP-Track: A framework for superresolved tracking
por: Sgouralis, Ioannis, et al.
Publicado: (2023)

BNP and NT-proBNP in patients with acute myocardial infarction complicated by cardiogenic shock: results from the IABP Shock trial
por: Lemm, H, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ilimbj2ocbqvqukrbggrstibg1